RIGHT TO HEALTHCARE: A DOCTRINAL STUDY OF COMPULSORY LICENSING OF MEDICINES IN INDIA

Authors

  • Prof. (Dr.) K.S. Gopalakrishnan Principal, Government Law College, Coimbatore

DOI:

https://doi.org/10.29121/shodhkosh.v4.i1.2023.5242

Keywords:

Compulsory Licensing, Government Use, Access To Medicines, Research and Development

Abstract [English]

In today’s world, each one relies on one or more pills to survive and extend their life amid new diseases. Though the advancement of science and technology certainly resulted in numerous changes in society; it has not come up with a panacea to cure the most challenging survival issue which is to combat poverty and disparity. Pharmaceutical companies are like a demi-god and they decide who should live and who not. Patent for R&D to encourage and incentivize creators has, on the other hand, posed a threat to the public in accessing and affording the patented products, especially in the case of medicine and health. The disparity among world nations and the application of one general rule to overcome the situation concerning access the medicine is not a proper solution. However compulsory licensing issued to balance the disadvantages caused by issuing patents has to be analyzed concerning its working. Hence this article would throw light on the use of the compulsory license by the government with special reference to accessing medicines. To analyze the same this paper would extensively discuss the Conceptual viewpoint of compulsory licensing, the phase of the patent in public health, use of the compulsory license by the government with special reference to accessing medicines.

References

Jason Mirabito, Compulsory Patent Licensing for the United States: A Current Proposal, 57 J. PAT. OFF. Soc'y 404 (1975). 7 Ganguli, P. (1999, December). Towards TRIPs compliance in India: The Patents Amendment Act 1999 and implications. World Patent Information, 21(4), 279–287.

Camilla Alexandra Hrdy & Daniel Harris Brean, The Patent Law Origins of Science Fiction.

D. Yang, Compulsory Licensing: For Better or For Worse, the Done Deal Lies in the Balance, 17 Journal of Intellectual Property Rights 76 (2012).

Ganguli, P. (1999, December). Towards TRIPs compliance in India: The Patents Amendment Act 1999 and implications. World Patent Information, 21(4), 279–287. DOI: https://doi.org/10.1016/S0172-2190(00)00012-0

Gilead Announces Generic Licensing Agreements to Increase Access to Hepatitis C Treatments in Developing Countries, https://www.gilead.com/news-and-press/press-room/press-releases/2014/9/gilead-announces-genericlicensing-agreements-to-increase-access-to-hepatitis-c-treatments-in-developing-countries

History of Indian Patent System, Intellectual Property India, https://ipindia.gov.in/history-of-indian-patentsystem.

Natco Pharma Ltd. v. Bayer Corporation & The Controller of Patents, Madras & Others, (2013) 10 SCC 463.

Rupali Mukherjee, Bristol-Myers misleading HC in patent case, TOI , Sep. 14, 2013, https://timesofindia.indiatimes.com/business/india-business/bristol-myers-misleading-hc-in-patentcase/articleshow/22568901.cms

Downloads

Published

2023-06-30

How to Cite

K.S. Gopalakrishnan. (2023). RIGHT TO HEALTHCARE: A DOCTRINAL STUDY OF COMPULSORY LICENSING OF MEDICINES IN INDIA. ShodhKosh: Journal of Visual and Performing Arts, 4(1), 4301–4309. https://doi.org/10.29121/shodhkosh.v4.i1.2023.5242